U.K. Proposes Prescription-Only Status For Pseudoephedrine Products
This article was originally published in The Tan Sheet
Executive Summary
The U.K. Medicines and Healthcare products Regulatory Agency is proposing prescription status for pseudoephedrine- and ephedrine-containing drugs in order to prevent the illegal manufacture of methamphetamine